Gil-Montoya JA, Gerez Muñoz MJ, Triviño-Ibáñez EM, Rosel E, Bravo M, Rómero-Fábrega JC, Morales-Santana S, Gómez-Río M. Relationship between salivary lactoferrin level and brain amyloid load in periodontal and non-periodontal subjects. Med Oral Patol Oral Cir Bucal. 2026 Jan 1;31 (1):e118-e123.
doi:10.4317/medoral.27612
https://dx.doi.org/doi:10.4317/medoral.27612
1. Olsen
I. Possible effects of Porphyromonas gingivalis on the blood-brain
barrier in Alzheimer's disease. Expert Rev Anti Infect Ther.
2021;19(11):1367-1371
https://doi.org/10.1080/14787210.2021.1925540
PMid:33938372
2. Cai
Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q. Role of blood-brain barrier
in Alzheimer's disease. J Alzheimers Dis.
2018;63(4):1223-1234
https://doi.org/10.3233/JAD-180098
PMid:29782323
3.
Darveau RP, Hajishengallis G, Curtis MA. Porphyromonas gingivalis as
a potential community activist for disease. J Dent Res.
2012;91(9):816-820
https://doi.org/10.1177/0022034512453589
PMid:22772362
PMCid:PMC3420389
4.
Ilievski V, Zuchowska PK, Green SJ, Toth PT, Ragozzino ME, Le K, et
al. Chronic oral application of a periodontal pathogen results in
brain inflammation, neurodegeneration and amyloid beta production in
wild type mice. PLoS One.
2018;13(10):e0204941
https://doi.org/10.1371/journal.pone.0204941
PMid:30281647
PMCid:PMC6169940
5. Beydoun MA, Beydoun HA,
Hossain S, El-Hajj ZW, Weiss J, Zonderman AB. Clinical
and bacterial markers of periodontitis and their association with
incident all-cause and Alzheimer's disease dementia in a large
national survey. J Alzheimers Dis.
2020;75(1):157-172
https://doi.org/10.3233/JAD-200064
PMid:32280099
PMCid:PMC11008556
6.
Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, et
al. Periodontal pathogens and associated intrathecal antibodies in
early stages of Alzheimer's disease. J Alzheimers Dis.
2018;66(1):105-114
https://doi.org/10.3233/JAD-180620
PMid:30223397
7. Olsen
I, Singhrao SK. Can oral infection be a risk factor for Alzheimer's
disease? J Oral Microbiol.
2015;7:29143
https://doi.org/10.3402/jom.v7.29143
PMid:26385886
PMCid:PMC4575419
8.
Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al.
Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for
disease causation and treatment with small-molecule inhibitors. Sci
Adv.
2019;5(1):eaau3333
https://doi.org/10.1126/sciadv.aau3333
PMid:30746447
PMCid:PMC6357742
9. Gonzalez-Sanchez M,
Bartolome F, Antequera D, Puertas-Martin V, Gonzalez P, Gomez-Grande
A, et al. Decreased
salivary lactoferrin levels are specific to Alzheimer's disease.
EBioMedicine.
2020;57:102834
https://doi.org/10.1016/j.ebiom.2020.102834
PMid:32586758
PMCid:PMC7378957
10.
Municio C, Carro E. Implication of salivary lactoferrin and
periodontal-mediated infections in Alzheimer's disease. Neural Regen
Res.
2023;18(12):2691-2692
https://doi.org/10.4103/1673-5374.373712
PMid:37449625
PMCid:PMC10358677
11.
Antequera D, Carrero L, Gonzalez-Sanchez M, Cantero JL, Orive G,
Municio C, Carro E. Reduced salivary lactoferrin levels in
early-onset alzheimer's disease. Aging Dis.
2024;15(3):945-947
https://doi.org/10.14336/AD.2023.0819
PMid:37815910
12.
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO,
et al. Mild cognitive impairment-beyond controversies, towards a
consensus: Report of the International Working Group on Mild
Cognitive Impairment. J Intern Med.
2004;256(3):240-246
https://doi.org/10.1111/j.1365-2796.2004.01380.x
PMid:15324367
13.
Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et
al. Preclinical Alzheimer's disease: Definition, natural history, and
diagnostic criteria. Alzheimers Dement.
2016;12(3):292-323
https://doi.org/10.1016/j.jalz.2016.02.002
PMid:27012484
PMCid:PMC6417794
14. Solis-Urra P,
Molina-Hidalgo C, Garcia-Rivero Y, Costa-Rodriguez C, Mora-Gonzalez
J, Fernandez-Gamez B, et al. Active
gains in brain using exercise during aging (AGUEDA): Protocol for a
randomized controlled trial. Front Hum Neurosci.
2023;17:1168549
https://doi.org/10.3389/fnhum.2023.1168549
PMid:37284481
PMCid:PMC10239947
15.
Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH,
et al. SNMMI procedure standard/EANM practice guideline for amyloid
PET imaging of the brain 1.0. J Nucl Med.
2016;57(8):1316-1322
https://doi.org/10.2967/jnumed.116.174615
PMid:27481605
16.
Sabri O, Seibyl J, Rowe C, Barthel H. Beta-amyloid imaging with
florbetaben. Clin Transl Imaging.
2015;3(1):13-26
https://doi.org/10.1007/s40336-015-0102-6
PMid:25741488
PMCid:PMC4339690
17.
Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, et
al. Cerebral amyloid-beta PET with florbetaben (18F) in patients with
Alzheimer's disease and healthy controls: A multicentre phase 2
diagnostic study. Lancet Neurol.
2011;10(5):424-435
https://doi.org/10.1016/S1474-4422(11)70077-1
PMid:21481640
18.
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of
periodontitis: Framework and proposal of a new classification and
case definition. J Clin Periodontol. 2019;46(7):787
https://doi.org/10.1111/jcpe.12945
PMid:29926495
19.
Kruzel ML, Zimecki M, Actor JK. Lactoferrin in a context of
inflammation-induced pathology. Front Immunol.
2017;8:1438
https://doi.org/10.3389/fimmu.2017.01438
PMid:29163511
PMCid:PMC5681489
20.
Fulop T, Itzhaki RF, Balin BJ, Miklossy J, Barron AE. Role of
microbes in the development of Alzheimer's disease: State of the
art-An international symposium presented at the 2017 IAGG Congress in
San Francisco. Front Genet.
2018;9:362
https://doi.org/10.3389/fgene.2018.00362
PMid:30250480
PMCid:PMC6139345
21.
Carro E, Bartolome F, Bermejo-Pareja F, Villarejo-Galende A, Molina
JA, Ortiz P, et al. Early diagnosis of mild cognitive impairment and
Alzheimer's disease based on salivary lactoferrin. Alzheimers Dement
(Amst).
2017;8:131-138
https://doi.org/10.1016/j.dadm.2017.04.002
PMid:28649597
PMCid:PMC5470603
22.
Bermejo-Pareja F, Del Ser T, Valenti M, de la Fuente M, Bartolome F,
Carro E. Salivary lactoferrin as biomarker for Alzheimer's disease:
Brain-immunity interactions. Alzheimers Dement.
2020;16(8):1196-1204
https://doi.org/10.1002/alz.12107
PMid:32543760
PMCid:PMC7984071
23.
Ramenzoni LL, Hofer D, Solderer A, Wiedemeier D, Attin T, Schmidlin
PR. Origin of MMP-8 and lactoferrin levels from gingival crevicular
fluid, salivary glands and whole saliva. BMC Oral Health.
2021;21(1):385
https://doi.org/10.1186/s12903-021-01743-5
PMid:34353321
PMCid:PMC8340507
24.
Gleerup HS, Jensen CS, Hogh P, Hasselbalch SG, Simonsen AH.
Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic
biomarker for Alzheimer's disease in a mixed memory clinic
population. EBioMedicine.
2021;67:103361
https://doi.org/10.1016/j.ebiom.2021.103361
PMid:33975253
PMCid:PMC8122152